Pancreatic Cancer News

Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.

Nov

05

Obesity Linked To Specific Cancers

About 100,500 new cases of cancer are caused by obesity every year, according to the most comprehensive attempt ever to estimate the cancers attributed to extra weight. The analysis, released today by the American Institute for Cancer Research, is based on updated cancer data and a report released earlier this year by a panel of experts. Among the types of cancer most strongly linked to excess body fat:

Nov

04

Stuffed Acorn Squash Makes A Hearty Entree

Mollie Katzen's latest cookbook urges beginners to take on her challenge with easy recipes, such as this acorn squash entree. Use plain raw almonds, not roasted or salted, Katzen writes, and don't chop them too fine. You can cook the rice and bake the acorn squash at the same time.

Nov

04

Light Stews Still Hearty: Reduce Fat And Salt In Fall Soups

If you're watching your weight, soup can be deceptive. What could be more harmless for lunch or a light dinner? Not so fast. Depending on the recipe, some soups are full of cream and cheese, or sometimes worse, they start with a roux. In place of cream and butter, add flavor to soup with lots of vegetables, beef broth and dried and fresh herbs.

Nov

02

U.S. Researchers Rule Out Link Between Hepatitis B, Pancreatic Cancer

U.S. researchers have found that hepatitis B does not increase the risk for pancreatic cancer, a conclusion contradicting a previous study that found a link between the two. The new study by researchers at Henry Ford Hospital was presented at the on-going annual meeting of the American Association for the Study of Liver Diseases in Boston.

Oct

31

Coffee Brims With Health Benefits, Researchers Say

Drink up, coffee lovers. Not only is coffee aromatic and delicious, it's good for you. Who says? None other than Harvard Medical School. Once considered questionable for your health, it turns out that the beloved beverage is actually healthful in moderation. That means a few cups a day.

Oct

27

NeoPharm Submits Application For A Multicenter, Open-Label, Phase II Study Of LE-DT For Locally Advanced Or Metastatic Pancreatic Cancer Patients As A Frontline Treatment

NeoPharm, Inc. today announced that it has submitted a Phase II protocol to the FDA for the study of liposome entrapped docetaxel (LE- DT), a novel, proprietary liposomal delivery system of docetaxel, the active ingredient of Taxotere(R), for locally advanced or metastatic pancreatic cancer patients.

Oct

22

Chronic Pain Treatments Work Better Together, Says Anesthesiologist

People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs. A new, federally-funded study by Queen's University researchers has found that taking the drugs together is a more effective treatment than taking either of them individually.

Oct

22

Researchers From National Institutes of Health Report Details Of New Studies And Findings In The Area Of Pancreatic Cancer

We conducted a two-stage genome-wide association study of pancreatic cancer, a cancer with one of the lowest survival rates worldwide. We genotyped 558,542 SNPs in 1,896 individuals with pancreatic cancer and 1,939 controls drawn from 12 prospective cohorts plus one hospital-based casecontrol study, scientists writing in the journal Nature Genetics report.

Oct

08

New Pancreatic Cancer Study Results From M.T. Mueller Et Al Described

Pancreatic cancers contain exclusively tumorigenic cancer stem cells (CSCs), which are highly resistant to chemotherapy, resulting in a relative increase in CSC numbers during gemcitabine treatment. Signaling through sonic hedgehog and mammalian target of rapamycin (mTOR), respectively, may be essential for CSC self-renewal and could represent putative targets for novel treatment modalities, scientists in Madrid, Spain report.

Oct

07

New Anti-Cancer Drug Undergoing Testing

A U.S. Phase 1 clinical trial is under way to determine if a new anti-cancer drug is safe and effective for use in patients with solid cancer tumors. The drug, currently called EP-100, is designed to treat common breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers. It is being tested by TGen Clinical Research Services at Scottsdale (Ariz.) Healthcare's Piper Cancer Center.

Page(s): Prev 1 2 3 4 5 6 7 ...4344 Next 

We care about your feedback. Let us know how we can improve your CancerCompass experience.